Russillo Thomas R 4
4 · WATSON PHARMACEUTICALS INC · Filed Dec 17, 2010
Insider Transaction Report
Form 4
Russillo Thomas R
EVP & Pres US Generics Div
Transactions
- Exercise/Conversion
Common Stock, par value $0.0033
2010-12-15$25.86/sh+11,598$299,924→ 74,968 total - Exercise/Conversion
Non-Qualified Options to Purchase Common Stock
2010-12-15−48,402→ 0 totalExercise: $25.86From: 2009-12-31Exp: 2016-09-05→ Common Stock, par value $0.0033 (48,402 underlying) - Exercise/Conversion
Common Stock, par value $0.0033
2010-12-15$25.86/sh+48,402$1,251,676→ 123,370 total - Sale
Common Stock, par value $0.0033
2010-12-15$50.00/sh−60,000$3,000,000→ 63,370 total - Exercise/Conversion
Incentive Stock Options to Purchase Common Stock
2010-12-15−11,598→ 0 totalExercise: $25.86From: 2009-12-31Exp: 2016-09-05→ Common Stock, par value $0.0033 (11,598 underlying)
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.